Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Melissa C. Davis"'
Autor:
Shodeinde A Coker, David A Pastel, Melissa C Davis, Elizabeth M Bengtson, Camilo E Fadul, Lionel D Lewis
Publikováno v:
SAGE Open Medical Case Reports, Vol 5 (2017)
Background/Objectives: Neurotoxicity is a serious and sometimes fatal adverse effect that can occur following methotrexate treatment. We describe two adult patients with hematological malignancies with methotrexate encephalopathy who recovered with d
Externí odkaz:
https://doaj.org/article/8c663e2b1ec14a2a9614d3e1a48cf209
Autor:
Brock C. Christensen, Alissa A. Thomas, Arti B. Gaur, Marc S. Ernstoff, Gilbert J. Rahme, Camilo E. Fadul, Sandra E. Steel, Chery A. Whipple, Melissa C. Davis, Thomas H. Hampton, Jan L. Fisher, Lionel D. Lewis, Gregory J. Tsongalis
Publikováno v:
Cancer Immunology, Immunotherapy. 66:379-389
Vascular endothelial growth factor (VEGF), in addition to being pro-angiogenic, is an immunomodulatory cytokine systemically and in the tumor microenvironment. We previously reported the immunomodulatory effects of radiation and temozolomide (TMZ) in
Autor:
Evelyn Schlosser, Melissa C. Davis, Lanelle Jalowiec, Linda P. Mason, Camilo E. Fadul, David Nalepinski, Katherine Thorley, Jennifer Hong, Natalie B. Riblet, Nancy L. Kennedy, Lara K Ronan, Tobi J. Cooney, Sabrina Richie, Jennifer Snide
BACKGROUND: Patients with glioma are at high risk for tumor and treatment related complications. Few guidelines exist to direct the management of these supportive care needs. Our prior work suggests that a standardized clinical care pathway can impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af223d78ef410c4db821cafcc328ea03
https://europepmc.org/articles/PMC4638849/
https://europepmc.org/articles/PMC4638849/
Autor:
Jennifer Hong, Katherine Thorley, Lanelle Jalowiec, Natalie B.V. Riblet, Nancy L. Kennedy, Melissa C. Davis, David Nalepinski, Evelyn Schlosser, Linda P. Mason, Tobi J. Cooney, Camilo E. Fadul, Lara Kunschner Ronan, Jennifer Snide, Sabrina Richie
Publikováno v:
Neuro-oncology practice. 3(3)
BackgroundPatients with glioma are at increased risk for tumor-related and treatment-related complications. Few guidelines exist to manage complications through supportive care. Our prior work suggests that a clinical care pathway can improve the car
Publikováno v:
Journal of Colloid and Interface Science. 255:391-402
We investigate the influence of confinement on the steady state microstructure of emulsions sheared between parallel plates, in a regime where the average droplet dimension is comparable to the gap width between the confining walls. Utilizing droplet
Autor:
Lionel D. Lewis, Shodeinde A. Coker, David A. Pastel, Elizabeth M. Bengtson, Melissa C. Davis, Camilo E. Fadul
Publikováno v:
SAGE Open Medical Case Reports, Vol 5 (2017)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
Background/Objectives: Neurotoxicity is a serious and sometimes fatal adverse effect that can occur following methotrexate treatment. We describe two adult patients with hematological malignancies with methotrexate encephalopathy who recovered with d
Autor:
Melissa C. Davis, Victoria Sherry
Publikováno v:
Clinical journal of oncology nursing. 15(5)
Hypertrophic osteoarthropathy is a paraneoplastic syndrome most often found in non-small cell lung cancer. Diagnosis is confirmed by the presence of clubbing on physical examination and periostitis on bone scintigram, and the syndrome generally resol
Autor:
Hang Lee, Melissa C. Davis, Makoto Okazaki, Amanda V. de la Paz, Elaine W. Yu, Jason J. Wyland, Robert M. Neer, Joel S. Finkelstein
Publikováno v:
Bone. 48(4)
Once-daily injections of teriparatide initially increase biochemical markers of bone formation and resorption, but markers peak after 6–12 months and then decline despite continued treatment. We sought to determine whether increasing teriparatide d
Autor:
Konstantin H. Dragnev, Khushboo A Shah, Camilo E. Fadul, Clifford J. Eskey, Evelyn M Brosnan, Melissa C. Davis
Publikováno v:
Journal of Clinical Oncology. 33:e19059-e19059
e19059 Background: About 30-44% of patients with non-small cell lung cancer (NSCLC) will develop brain metastases, with a median survival if untreated of less than 3 months. Treatment options are l...